成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天
Shanghai Yifei Biotechnology Co. , Ltd.
Firmenname:
Shanghai Yifei Biotechnology Co. , Ltd.
Telefon:
021-65675885
E-Mail:
customer_service@efebio.com
Nationalit?t:
China
URL:
http://www.efebio.com
Produkte insgesamt:
11974
112
113
114
115
116
117
118
119
120
Produktkatalog
caffeic acid glucoside
892501-29-0
C15H18O9
2,2',5-Tribromobiphenyl
59080-34-1
C12H7Br3
PBB No. 26
59080-35-2
C12H7Br3
3,4,5-Trichlorophenol acetate
59190-61-3
C8H5Cl3O2
Ergosinine
596-88-3
C30H37N5O5
2,6-Diethylnaphthalene
59919-41-4
C14H16
PBB-No. 49
60044-24-8
C12H6Br4
PBB No. 53
60044-25-9
C12H6Br4
5,10,15,20-Tetraoxatetracosane-1,24-diol
61136-08-1
C20H42O6
1,2-Dichlorobutane
1,2-Dichlorbutan
616-21-6
C4H8Cl2
2,3,4-Trichlorophenol acetate
61925-89-1
C8H5Cl3O2
Carbophenothion-methyl-sulfone
62059-34-1
C9H12ClO4PS3
PCB No. 50
62796-65-0
C12H6Cl4
6-Nitrobenz[a]pyrene
63041-90-7
C20H11NO2
Testosterone-d4
638163-36-7
C19H28O2
Sudan Black B Impurity 1
2,3-Dihydro-2,2-dimethyl-4-[[1-naphthyl-4-(phenylazo)]azo]-1H-perimidin
65322-64-7
C29H24N6
4-Cyano-4'-undecylbiphenyl
4'-Undecyl[1,1'-biphenyl]-4-carbonitril
65860-74-4
C24H31N
Ivuxolimab
2225940-98-5
Balstilimab
2230167-06-1
Ecromeximab
292819-64-8
Tacatuzumab
476413-07-7
Ertumaxomab
509077-99-0
Besilesomab
537694-98-7
Mapatumumab
658052-09-6
Naptumomab Estafenatox
676258-98-3
HuCC49
823788-82-5
Romosozumab
909395-70-6
Alacizumab
934216-54-3
Oportuzumab
945228-48-8
JYS002
1448189-66-9
C26H36N4O5S
Thalidomide-4-O-CH2-COO(t-Bu)
1950635-36-5
C19H20N2O7
Thalidomide-NH-(CH2)2-NH-Boc
1957235-57-2
C20H24N4O6
Thalidomide-NH-CH2-COO(t-Bu)
2093386-23-1
C19H21N3O6
JYS001
2111829-84-4
C23H30N4O5S
Thalidomide-4-NH-PEG2-COO(t-Bu)
2140807-16-3
C24H31N3O8
Thalidomide-4-NH-PEG1-COO(t-Bu)
2140807-19-6
C22H27N3O7
Thalidomide-4-NH-PEG1-NH-Boc
2154342-17-1
C22H28N4O7
JYS005
2306389-02-4
C35H53N5O6S
JYS003
2361119-87-9
C31H45N5O6S
JYS006
2409007-41-4
C31H45N5O7S
JYS004
2412055-00-4
C33H49N5O6S
Thalidomide-5-O-CH2-COO(t-Bu)
2682112-10-1
C19H20N2O7
JYS008
2827750-24-1
C30H42N4O6S
JYS009
2827750-25-2
C32H46N4O6S
Glucuronic Acid
Glucuronsure
576-37-4
C6H10O7
4'-Cyano-4-nonyloxybiphenyl
4'-(Nonyloxy)[1,1'-biphenyl]-4-carbonitril
58932-13-1
C22H27NO
Roledumab
1174008-79-7
Narnatumab
1188275-92-4
Pateclizumab
1202526-59-7
Refanezumab
1233953-61-1
Ifabotuzumab
1234137-51-9
Indatuximab
1238517-16-2
Actoxumab
1245634-25-6
Radretumab
1253180-81-2
Coltuximab
1269764-99-9
Perakizumab
1331830-76-2
Olendalizumab
1337966-73-0
Bimagrumab
1356922-05-8
Dinutuximab
1363687-32-4
Otlertuzumab
1372645-37-8
Landogrozumab
1391726-30-9
Cusatuzumab
1399546-01-0
Denintuzumab
1399672-02-6
Vadastuximab
1436390-63-4
Satumomab
144058-40-2
Evinacumab
1446419-85-7
Capromab
145464-28-4
C10H15N5O11P2
Clivatuzumab
1462876-11-4
Vandortuzumab
1471985-92-8
Arcitumomab
154361-48-5
Altumomab
156586-92-4
Domagrozumab
1629605-31-7
Tabituximab
1644134-10-0
Nofetumomab
165942-79-0
Dezamizumab
1662664-56-3
Sirtratumab
1824663-82-2
Samrotamab
2052591-32-7
Tositumomab
208921-02-2
Apamistamab
2097132-02-8
Ontamalimab
2098790-40-8
Cibisatamab
2101242-53-7
Erlizumab
211323-03-4
Oregovomab
213327-37-8
Ieramilimab
2137049-37-5
Tamrintamab
2148325-59-9
Lintuzumab
166089-32-3
Zolimomab
141483-72-9
Thalidomide-5-NH-CH2-COO(t-Bu)
2412056-28-9
C19H21N3O6
Thalidomide-4-NH-PEG3-NH-Boc
2204246-03-5
C26H36N4O9
JYS007
2162120-75-2
C33H49N5O8S
Thalidomide-NH-(CH2)3-NH-Boc
2093386-36-6
C21H26N4O6
VH032-NH-CO-CH2-NHBoc
2010986-19-1
C29H41N5O6S
Derlotuximab
340013-96-9
Clothianidin-urea
634192-72-6
C6H8ClN3OS
Nacolomab Tafenatox
150631-27-9
Biciromab
138783-13-8
Imciromab
126132-83-0
Thalidomide-4-NH-PEG1-NH2 TFA
2490499-21-1
C19H21F3N4O7
VH032-NH-CO-CH2-Br
2379404-33-6
C24H31BrN4O4S
Stamulumab
705287-60-1
112
113
114
115
116
117
118
119
120
Copyright 2019 ? ChemicalBook. All rights reserved